Press Releases
December 9, 2024
Endo Receives U.S. FDA Approval of Manufacturing Facility in Indore, India
20,000-square-foot site increases Endo's sterile injectable production capacityThis marks the site's first U.S. FDA approvalEndo is investing and innovating in its Injectable Solutions business
